New Elegant Method for Rapid Recovery of Anti-Cancer Agent At-211

One isotope of the extremely rare element Astatine has shown promise in the treatment of malignant brain tumors, ovarian cancer, advanced blood and lymph system cancers. However, because of its short half-life, scientists need a rapid system with high yield to recover the isotope, At-211, for medical use. Scientists have developed a new purification system that results in a high purity, high yield recovery of At-211.

Harnessing the Power of Uranium to Treat Disease

Scientists have developed a new system for producing radioisotopes for cancer therapy. The system uses a simple radionuclide generator to repeatedly separate thorium-226 from its longer-lived parent isotope, uranium-230. The uranium-230/thorium-226 pair has the unique advantage of emitting multiple alpha particles as they decay, delivering more destructive energy to cancer cells.